Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

  • This share is currently suspended. It was suspended at a price of 0.75
  • There is currently no data for BELL

Form 8.3 - Belluscura PLC

24 Nov 2023 14:06

Form 8.3 - Belluscura PLC

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbones Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBelluscura PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure23/11/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p Ord
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:2,363,9841.71%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:2,363,9841.71%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1p ordSale18,11523p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
1p ordinaryService level change from Ex/o to Discretionary18,115 shares 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:24/11/2023
Contact name:Liam Smith – Compliance Department
Telephone number:0151 243 7101

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
2nd Dec 20257:00 amRNSCancellation - Belluscura plc
5th Nov 20259:47 amRNSIntention to appoint Administrator Update
31st Oct 202512:15 pmRNSIntention to appoint Administrator
30th Oct 202511:30 amRNSReplacement Statement re US Subsidiary Update
30th Oct 202510:38 amRNSStatement re US Subsidiary Chapter 7 Update
28th Oct 20255:32 pmRNSUpdate re Proposed Fundraise
22nd Sep 20257:00 amRNSDirectorate Change
12th Sep 20254:57 pmRNSBoard Appointment
26th Aug 20256:00 pmRNSSuspended Companies Notice - Deletion
11th Aug 20257:00 amRNSUpdate re Strategic Review and Proposed Fundraise
1st Jul 20257:30 amRNSSuspension - Belluscura PLC
30th Jun 20257:00 amRNSStrategic Review Update and Proposed Fundraising
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
18th Jun 20255:01 pmRNSHolding(s) in Company
13th May 202512:54 pmRNSResponse to Share Price Movement
9th May 20257:00 amRNSTrading update & commencement of strategic review
16th Apr 20257:00 amRNSTrading Update and Directorate Change
8th Apr 20252:45 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSStatement re proposed imposition of Tariffs
27th Mar 20253:15 pmRNSHolding(s) in Company
10th Mar 20255:49 pmRNSHolding(s) in Company
6th Mar 20254:21 pmRNSHolding(s) in Company
6th Mar 20251:08 pmRNSHolding(s) in Company
5th Mar 20252:21 pmRNSHolding(s) in Company
4th Mar 20253:50 pmRNSHolding(s) in Company
28th Feb 20253:44 pmRNSReplacement: Result of General Meeting
28th Feb 20251:32 pmRNSResult of General Meeting
13th Feb 20257:30 amRNSHolding(s) in Company
12th Feb 20257:00 amRNSPosting of Circular and Notice of General Meeting
11th Feb 20257:00 amRNSResult of oversubscribed WRAP Retail Offer
7th Feb 20257:05 amRNSLaunch of WRAP Retail Offer
7th Feb 20257:00 amRNSResult of Share Placing
6th Feb 20255:22 pmRNSProposed Share Placing
5th Feb 20257:30 amRNSRule 19.6(c) confirmation of post-offer intentions
20th Dec 20243:20 pmRNSAppointment of Allenby Capital as Joint Broker
11th Dec 20243:21 pmRNSHolding(s) in Company
22nd Nov 20247:00 amRNSNew $4million Credit Facility
12th Nov 20244:34 pmRNSHolding(s) in Company
28th Oct 20247:00 amRNSTrading Update
26th Sep 20247:00 amRNSHalf-year Report
13th Sep 20241:37 pmRNSHolding(s) in Company
12th Sep 20243:05 pmRNSHolding(s) in Company
27th Aug 20242:17 pmRNSResult of General Meeting
27th Aug 20247:00 amRNSAGM Trading Statement
2nd Aug 20247:00 amRNSNotice of AGM
31st Jul 20241:11 pmRNSTotal Voting Rights
19th Jul 202410:36 amRNSDirector/PDMR Shareholding
11th Jul 202411:30 amRNSDirectorate Change
8th Jul 202412:45 pmRNSResult of General Meeting
4th Jul 20241:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.